ZeroStack Corp. is classed by the SEC under Wholesale-Drugs, Proprietaries & Druggists' Sundries (industry code 5122), based in Toronto. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $36 million and a loss of $120 million (its filed statements).
Distribution businessWholesale-Drugs, Proprietaries & Druggists' SundriesTorontofilings since 20198 of 9 filed, 1 estimated
Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a distribution business: prior from its industry code (SEC 5122, Wholesale-Drugs, Proprietaries & Druggists' Sundries); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.
The grade, in three tenses
Headline 3.0 out of ten, 8 of 9 metrics filed and 1 estimated: past 4.9 out of ten, present 2.5 out of ten, future 2.1 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.
The nine metrics
Surviving crises (past): 3.5 out of ten. 5 warning events since 2019; the latest 2025-08-27. 35th percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Track record (past): 3.8 out of ten. +41.2% a year over 5 filed years; profitable in 1 of 5. 38th percentile among 8 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Shareholder treatment (past): 9.5 out of ten. CrossAssetData estimate 9.5/10, confidence 35 of 100 (one part). 95th percentile among 10 sector filers. A CrossAssetData estimate, not a filed reading: one part, confidence 35 of 100; a filing that carries the missing parts replaces this estimate with the filed reading.
Financial health (present): 2.6 out of ten. ROE -170%: lost 170¢ per shareholder dollar. Leverage 46%: owes 46¢ per asset dollar. 26th percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Industry position (present): 2.8 out of ten. bottom 28% of 10 in its family; net margin -335.6%. 28th percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Leadership (present): 1.8 out of ten. bottom 18% of 9 in its family for leadership; chief executive since 2025. 18th percentile among 9 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
Room to expand (future): 3.2 out of ten. bottom 32% of 10 in its family for room to expand. 32nd percentile among 10 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Growth drivers (future): 2.3 out of ten. bottom 23% of 8 in its family for growth drivers. 23rd percentile among 8 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Expectations vs reality (future): 0.7 out of ten. bottom 7% of 7 in its family for expectations against reality. 7th percentile among 7 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
The filing record
Newest annual report: Form 10-K filed 2026-02-27 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-07-31 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2023-08-10 for the period ended 2023-08-09 (on EDGAR). Newest filing: Form EFFECT, 2026-09-15. Filings on record since 2019. Read from EDGAR 2026-10-12.
Who runs it
Reis-Faria, Daniel (CEO); Starke, Clifford (CEO); Heinrich, Michael (Executive Chairman); Rong, Rudy (President); Vaiman, Dany (CFO); Leventhal, Manfred (director); Woo, Edward (director); Zeifman, Laurence (director); Brown, Michael John (director); Wolkin, Harold (director). 10 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-09-30.
Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.